EARSWITCH LTD

12358776
Active Manchester

Research and experimental development on biotechnology

12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EARSWITCH LTD

12358776

Research and experimental development on biotechnology

Founded 11 Dec 2019 Active Manchester, England 12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 26 Jan 2026 Next due 30 Sept 2027 15 months remaining
Confirmation Submitted 2 Jan 2026 Next due 24 Dec 2026 6 months remaining
Net assets £94K £352K 2025 year on year
Total assets £441K £150K 2025 year on year
Total Liabilities £347K £202K 2025 year on year
Charges 5
2 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

111 Piccadilly Manchester M1 2HY England

Website

www.example.com

Full company profile for EARSWITCH LTD (12358776), an active life sciences and medical technology company based in Manchester, England. Incorporated 11 Dec 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type unaudited-abridged
Next accounts 31 Dec 2026
Due by 30 Sept 2027 15 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2025)

Cash in Bank

£80.82k

Decreased by £87.33k (-52%)

Net Assets

£93.62k

Decreased by £351.65k (-79%)

Total Liabilities

£347.33k

Increased by £201.62k (+138%)

Turnover

N/A

Employees

12

Decreased by 2 (-14%)

Debt Ratio

79%

Increased by 54 (+216%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 4May 2023Seed
Investor 5May 2023Seed
Investor 6May 2023Seed

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 67,032 Shares £15.34m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Apr 2026418£15k£35.89
11 Dec 20251,000£40k£40
10 Dec 2025500£20k£40
4 Dec 20251,000£40k£40
4 Apr 2025722£17k£23.7

Officers

Officers

3 active
Status
Dominic John KeenDirectorBritishUnited Kingdom4917 Oct 2022Active
Gai Rosemary BennettDirectorBritishEngland5620 Feb 2024Active
Naseeb SinghDirectorBritishEngland4322 Jan 2024Active

Shareholders

Shareholders (25)

Nicholas Roy Gompertz
58.8%
100,200
Gmc Life Sciences Fund
19.8%
33,755

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Nicholas Roy Gompertz

British

Active
Notified 11 Dec 2019
Residence United Kingdom
DOB July 1967
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 May 2026ResolutionResolutions
18 May 2026MortgageMortgage Satisfy Charge Full
18 May 2026MortgageMortgage Satisfy Charge Full
8 May 2026CapitalAllotment of shares (GBP 1.71947) on 24 Apr 2026
22 Apr 2026ResolutionResolutions
28 May 2026 Resolution

Resolutions

18 May 2026 Mortgage

Mortgage Satisfy Charge Full

18 May 2026 Mortgage

Mortgage Satisfy Charge Full

8 May 2026 Capital

Allotment of shares (GBP 1.71947) on 24 Apr 2026

22 Apr 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Resolutions

2 weeks ago on 28 May 2026

Mortgage Satisfy Charge Full

4 weeks ago on 18 May 2026

Mortgage Satisfy Charge Full

4 weeks ago on 18 May 2026

Allotment of shares (GBP 1.71947) on 24 Apr 2026

1 months ago on 8 May 2026

Resolutions

1 months ago on 22 Apr 2026